Roland Baron
Corporate Officer/Principal chez Harvard Medical School
Profil
Roland Baron is the founder of ProSkelia SAS, which was founded in 2002.
He is currently the Chairman-Oral Medicine at Harvard School of Dental Medicine and a Professor at Harvard Medical School.
Dr. Baron was previously an Independent Non-Executive Director at Bone Therapeutics SA from 2015 to 2019.
He was also a Vice President at Aventis SA and Hoechst Marion Roussel, Inc. Additionally, he was the President & Chief Scientific Officer at Kyowa Kirin International Plc and ProStrakan, Inc. Dr. Baron was the President of The American Society for Bone & Mineral Research and a Professor at Yale School of Medicine from 1977 to 2007.
He received his doctorate degree from Université de Paris 5 René Descartes.
Postes actifs de Roland Baron
| Sociétés | Poste | Début |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | 01/01/2008 |
| Harvard School of Dental Medicine | Corporate Officer/Principal | 01/01/2008 |
Anciens postes connus de Roland Baron
| Sociétés | Poste | Fin |
|---|---|---|
| BIOSENIC SA | Directeur/Membre du Conseil | 12/06/2019 |
| Yale School of Medicine | Corporate Officer/Principal | 01/01/2007 |
ProSkelia SAS
 ProSkelia SAS Miscellaneous Commercial ServicesCommercial Services Part of Galapagos NV, ProSkelia SAS conducts bone disease research. The company is based in Romainville, France. The French company was founded by Roland Baron. ProSkelia was acquired by Galapagos Genomics NV from Kyowa Kirin International Plc on December 22, 2006 for $59.24 million. | Fondateur | - |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | President | 02/04/2006 |
| Hoechst Marion Roussel, Inc. | Corporate Officer/Principal | 01/01/2002 |
Formation de Roland Baron
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Aventis SA
 Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Health Technology |
ProSkelia SAS
ProSkelia SAS Miscellaneous Commercial ServicesCommercial Services Part of Galapagos NV, ProSkelia SAS conducts bone disease research. The company is based in Romainville, France. The French company was founded by Roland Baron. ProSkelia was acquired by Galapagos Genomics NV from Kyowa Kirin International Plc on December 22, 2006 for $59.24 million. | Commercial Services |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
| Hoechst Marion Roussel, Inc. | |
The American Society for Bone & Mineral Research
 The American Society for Bone & Mineral Research Miscellaneous Commercial ServicesCommercial Services The American Society for Bone & Mineral Research engages in bone, mineral and musculoskeletal research. The non-profit company is based in Washington. | Commercial Services |
Bone Therapeutics SA
 Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Bone Therapeutics SA is a cell therapy company, which engages in the regenerative therapy addressing for unmet medical needs in the field of bone diseases and orthopedics. Its products include Allob and JTA-004. The company was founded by Jacques Reymann on June 16, 2006 and is headquartered in Gosselies, Belgium. | Health Technology |
| Université de Paris 5 René Descartes | Consumer Services |
ProStrakan, Inc.
 ProStrakan, Inc. Pharmaceuticals: MajorHealth Technology Part of Kirin Holdings Co., Ltd., ProStrakan, Inc. develops, manufactures, and distributes prescription medicines. The company is based in Bridgewater, NJ. | Health Technology |
